Clinical Trials
Clinical Trials
MeRmaiD-1 Study
– Type: Phase III
– Objective: Determine the Efficacy of Adjuvant Durvalumab
– Setting: Multicenter, Double-blind, Placebo-controlled
– Population: Completely Resected Stage II-III NSCLC Patients
– Intervention: Durvalumab in Combination with Platinum-based Chemotherapy
MeRmaiD-2 Study
– Type: Phase III
– Objective: Evaluate Durvalumab Treatment for ctDNA+ Stage II-III NSCLC Patients
– Setting: Randomized, Double-blinded, Placebo-controlled, Multicenter
– Population: Stage II-III NSCLC Patients after Surgery and Curative Intent Therapy
CANOPY-A Study
– Type: Phase III
– Objective: Assess Canakinumab Efficacy and Safety as Adjuvant Therapy
– Setting: Multicenter, Randomized, Double-blind, Placebo-controlled
– Population: Adult Subjects with Completely Resected (R0) NSCLC Stages II-IIIA and IIIB (T>5cm N2)
Dissertation/Thesis
Echocardiographic manifestations of metabolic syndrome- a case-control study done under the guidance of Dr. Sudha Vidyasagar, HOD, Department of General Medicine, KMC, Manipal.
